These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 12587666)
1. Increased fibrillar beta-amyloid in response to human clq injections into hippocampus and cortex of APP+PS1 transgenic mice. Boyett KW; DiCarlo G; Jantzen PT; Jackson J; O'Leary C; Wilcock D; Morgan D; Gordon MN Neurochem Res; 2003 Jan; 28(1):83-93. PubMed ID: 12587666 [TBL] [Abstract][Full Text] [Related]
2. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway. Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589 [TBL] [Abstract][Full Text] [Related]
3. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease. Matsuoka Y; Picciano M; Malester B; LaFrancois J; Zehr C; Daeschner JM; Olschowka JA; Fonseca MI; O'Banion MK; Tenner AJ; Lemere CA; Duff K Am J Pathol; 2001 Apr; 158(4):1345-54. PubMed ID: 11290552 [TBL] [Abstract][Full Text] [Related]
4. Insulin-Like Growth Factor-1 Alleviates Expression of Aβ Song F; Liu T; Meng S; Li F; Zhang Y; Jiang L J Mol Neurosci; 2018 Dec; 66(4):595-603. PubMed ID: 30414017 [TBL] [Abstract][Full Text] [Related]
5. Intrahippocampal LPS injections reduce Abeta load in APP+PS1 transgenic mice. DiCarlo G; Wilcock D; Henderson D; Gordon M; Morgan D Neurobiol Aging; 2001; 22(6):1007-12. PubMed ID: 11755009 [TBL] [Abstract][Full Text] [Related]
6. miR-124 regulates cerebromicrovascular function in APP/PS1 transgenic mice via C1ql3. Li AD; Tong L; Xu N; Ye Y; Nie PY; Wang ZY; Ji LL Brain Res Bull; 2019 Nov; 153():214-222. PubMed ID: 31499089 [TBL] [Abstract][Full Text] [Related]
7. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions. van Groen T; Liu L; Ikonen S; Kadish I Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872 [TBL] [Abstract][Full Text] [Related]
8. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice. van Groen T; Kiliaan AJ; Kadish I Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076 [TBL] [Abstract][Full Text] [Related]
9. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease. Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037 [TBL] [Abstract][Full Text] [Related]
10. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice. Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368 [TBL] [Abstract][Full Text] [Related]
11. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice. Zhao G; Liu HL; Zhang H; Tong XJ Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition. Yamamoto M; Horiba M; Buescher JL; Huang D; Gendelman HE; Ransohoff RM; Ikezu T Am J Pathol; 2005 May; 166(5):1475-85. PubMed ID: 15855647 [TBL] [Abstract][Full Text] [Related]
13. Amyloid suppresses induction of genes critical for memory consolidation in APP + PS1 transgenic mice. Dickey CA; Gordon MN; Mason JE; Wilson NJ; Diamond DM; Guzowski JF; Morgan D J Neurochem; 2004 Jan; 88(2):434-42. PubMed ID: 14690531 [TBL] [Abstract][Full Text] [Related]
14. Age-related amyloid beta deposition in transgenic mice overexpressing both Alzheimer mutant presenilin 1 and amyloid beta precursor protein Swedish mutant is not associated with global neuronal loss. Takeuchi A; Irizarry MC; Duff K; Saido TC; Hsiao Ashe K; Hasegawa M; Mann DM; Hyman BT; Iwatsubo T Am J Pathol; 2000 Jul; 157(1):331-9. PubMed ID: 10880403 [TBL] [Abstract][Full Text] [Related]
15. Alteration of cortical EEG in mice carrying mutated human APP transgene. Wang J; Ikonen S; Gurevicius K; van Groen T; Tanila H Brain Res; 2002 Jul; 943(2):181-90. PubMed ID: 12101040 [TBL] [Abstract][Full Text] [Related]
16. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition. Fan R; DeFilippis K; Van Nostrand WE J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807 [TBL] [Abstract][Full Text] [Related]
17. The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice. Stanley M; Macauley SL; Caesar EE; Koscal LJ; Moritz W; Robinson GO; Roh J; Keyser J; Jiang H; Holtzman DM J Neurosci; 2016 Nov; 36(46):11704-11715. PubMed ID: 27852778 [TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes. Kurt MA; Davies DC; Kidd M; Duff K; Rolph SC; Jennings KH; Howlett DR Exp Neurol; 2001 Sep; 171(1):59-71. PubMed ID: 11520121 [TBL] [Abstract][Full Text] [Related]
19. Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation. Wilcock DM; DiCarlo G; Henderson D; Jackson J; Clarke K; Ugen KE; Gordon MN; Morgan D J Neurosci; 2003 May; 23(9):3745-51. PubMed ID: 12736345 [TBL] [Abstract][Full Text] [Related]
20. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]